Biomedical engineering sits at the intersection of engineering and medicine, applying principles from mechanical, electrical, chemical, and materials science to solve problems in healthcare. It’s the field responsible for everything from artificial joints to MRI machines to targeted cancer therapies. If a medical technology exists, a biomedical engineer likely helped design, build, test, or improve it.
How Engineering Meets Medicine
Biomedical engineering pulls from physics, chemistry, math, and computer science to study how the body works and to build tools that treat it. That breadth is the defining feature of the field. A biomedical engineer might spend one year modeling how blood flows through a damaged artery and the next designing a stent to fix it. The discipline spans dozens of subfields: biomechanics, biomaterials, tissue engineering, neural engineering, rehabilitation engineering, medical imaging, bioinformatics, pharmaceutical engineering, and clinical engineering, among others.
What ties these subfields together is the need to understand both engineering principles and human physiology. Designing a hip implant, for example, requires knowing the mechanical forces a joint experiences during walking and running, but also how bone and tissue respond to a foreign material over years of use.
Building Better Prosthetics and Implants
One of the most visible contributions of biomedical engineering is prosthetic limbs and implantable devices. Modern prosthetics have moved far beyond passive replacements. A 2024 study published in Nature Medicine demonstrated a neuroprosthetic leg controlled directly by the user’s nervous system. The interface used surgically connected pairs of opposing muscles with embedded sensors that read electrical signals from the remaining limb. In a group of seven leg amputees, this setup boosted the residual nerve signals by 18% compared to biologically intact values, allowing users to walk with a natural gait pattern. The bionic leg adapted continuously across different walking speeds, terrain types, and unexpected disruptions.
On the implant side, biomedical engineers select and test the materials that go inside the body. Hip replacements commonly use a polymer called PMMA or cobalt-chromium-molybdenum alloys, chosen because their stiffness can be matched to bone to prevent the surrounding tissue from weakening over time. Arterial stents rely on stainless steel or nickel-titanium alloys that can flex with each heartbeat without fracturing. Pure zinc has also emerged as a stent material because it offers enough mechanical strength while gradually dissolving in the body.
Medical Imaging Technology
Every time a doctor orders an MRI, CT scan, or ultrasound, the images are produced by technology that biomedical engineers designed and continue to refine. The work spans hardware and software: building the machines that capture signals from inside the body, then developing the algorithms that turn those signals into detailed images a radiologist can interpret.
Current research in the field includes elastography (using ultrasound or MRI to measure tissue stiffness, which helps identify tumors), advanced Doppler techniques for tracking blood flow, and neuroimaging methods that map brain structure in fine detail. These aren’t just incremental upgrades. Better imaging means catching diseases earlier, guiding surgeries more precisely, and monitoring treatment without invasive procedures.
Targeted Drug Delivery
Biomedical engineers design microscopic delivery vehicles that carry drugs directly to diseased cells while leaving healthy tissue alone. The most common approach uses nanoparticles, tiny capsules engineered with specific surface properties that determine where they go in the body and which cells they interact with.
Liposomes, a type of fat-based nanoparticle, can carry both water-soluble and oil-soluble drugs. Engineers modify their surfaces by attaching molecules like antibodies or folate that bind to receptors found on cancer cells. This turns the liposome into a guided missile: it circulates through the bloodstream, locks onto tumor cells that display the matching receptor, and delivers its payload directly. In one well-studied example, encapsulating the chemotherapy drug doxorubicin inside a liposome increased its effectiveness against tumors while significantly reducing the toxic side effects that make conventional chemotherapy so difficult to endure. The same principle works for nanoparticles that would otherwise cause inflammation at high doses. Wrapping them in a lipid carrier lowers the required concentration and improves delivery.
Tissue Engineering and Regenerative Medicine
Rather than replacing damaged tissue with metal or plastic, tissue engineering aims to grow new biological tissue from a patient’s own cells. The process starts with a scaffold, a three-dimensional structure that acts as a temporary framework. Cells are seeded onto or suspended within the scaffold, which provides physical support and guides how the cells organize, grow, and eventually form functional tissue.
Scaffolds need to meet several requirements at once. They must allow signaling molecules to diffuse through the structure so cells can communicate. They need to be stiff enough to hold their shape but flexible enough to let cells rearrange. They must encourage blood vessel and nerve growth into the new tissue. And they need to biodegrade at the right pace, dissolving as the new tissue matures and takes over structural support.
Engineers build these scaffolds from synthetic polymers, natural proteins like collagen, or combinations of both. For skin regeneration, researchers have used collagen gels seeded with skin cells to regrow hair follicles in lab settings. For harder tissues like teeth, electrospun polymer fibers loaded with a mineral similar to natural bone have been used to guide cell alignment and growth. Hydrogels, which are water-rich materials with a texture similar to biological tissue, allow cells to be suspended throughout the scaffold in three dimensions rather than just on the surface.
AI and Disease Diagnosis
Biomedical engineers increasingly work at the intersection of artificial intelligence and clinical diagnosis. Machine learning models, particularly a type called convolutional neural networks, excel at analyzing medical images. These systems learn to recognize patterns in X-rays, MRIs, CT scans, and ultrasound images that correlate with specific diseases.
The results are striking. A neural network trained on over 6,600 MRI brain scans achieved 99% accuracy in classifying stages of Alzheimer’s disease. Another model analyzing CT images from COVID-19 patients reached 98.5% accuracy in distinguishing infected from non-infected lungs. Brain tumor classification models trained on publicly available datasets achieved accuracies between 92.5% and 97.8% depending on the dataset. Kidney disease detection using ultrasound images paired with neural networks hit 99.6% accuracy.
These tools don’t replace radiologists or pathologists, but they can flag abnormalities faster than a human reviewing hundreds of scans, catch subtle patterns that might be missed, and help standardize diagnosis across different hospitals and clinicians.
Navigating Device Regulation
Biomedical engineers don’t just build medical devices. They also navigate the regulatory process that determines whether those devices can reach patients. The FDA classifies medical devices into three categories based on risk. Class I covers the lowest-risk devices and requires only general safety controls. Class II devices carry moderate risk and must meet additional “special controls,” which can include specific performance standards or labeling requirements. Class III devices, like implantable heart valves or neural stimulators, pose the highest risk and require a full premarket approval process with clinical evidence of safety and effectiveness.
Understanding these classifications shapes how engineers design and test their products from the very beginning. A device destined for Class III approval needs years of clinical trial data, which affects everything from materials selection to manufacturing processes to documentation.
Where Biomedical Engineers Work
The field’s job market reflects its diversity. Based on 2023 federal employment data, the largest concentration of biomedical engineers works in scientific research and development, with about 4,860 positions. Medical equipment and supplies manufacturing employs roughly 3,050, while wholesale distribution of professional equipment accounts for around 2,270. Pharmaceutical and medicine manufacturing employs about 1,810 biomedical engineers, and general hospitals account for approximately 1,020.
Pay varies by sector. Engineers in wholesale equipment distribution and research and development earn median salaries near $109,000 to $110,000 per year. Those in pharmaceutical manufacturing earn around $107,000, while hospital-based engineers earn closer to $90,600. The field’s range of employers means biomedical engineers can work in corporate R&D labs, startup medical device companies, pharmaceutical firms, university research centers, or directly within hospital systems managing and improving clinical technology.